Leeward Investments LLC MA Trims Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Leeward Investments LLC MA lowered its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 0.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 432,912 shares of the company’s stock after selling 1,890 shares during the period. Leeward Investments LLC MA owned 0.25% of Option Care Health worth $13,550,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Blue Trust Inc. increased its position in Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares during the period. GAMMA Investing LLC raised its position in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Trust Point Inc. boosted its holdings in shares of Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after buying an additional 622 shares during the period. Nisa Investment Advisors LLC boosted its stake in Option Care Health by 5.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after purchasing an additional 690 shares during the period. Finally, State of Alaska Department of Revenue boosted its position in Option Care Health by 3.8% during the 3rd quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock worth $621,000 after acquiring an additional 735 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Buying and Selling

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on OPCH. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Truist Financial lowered their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $38.00 to $27.00 in a research note on Monday. JMP Securities increased their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Finally, Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Trading Up 5.3 %

NASDAQ:OPCH opened at $23.50 on Thursday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $22.25 and a twelve month high of $34.63. The company has a market cap of $4.00 billion, a P/E ratio of 19.75, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. The business has a 50 day moving average price of $30.14 and a two-hundred day moving average price of $29.79.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.